Quốc gia: Úc
Ngôn ngữ: Tiếng Anh
Nguồn: Department of Health (Therapeutic Goods Administration)
formoterol fumarate dihydrate, Quantity: 6 microgram; beclometasone dipropionate, Quantity: 100 microgram; glycopyrronium bromide, Quantity: 12.5 microgram (Equivalent: glycopyrronium, Qty 10 microgram)
Chiesi Australia Pty Ltd
Inhalation, pressurised
Excipient Ingredients: ethanol absolute; norflurane; hydrochloric acid
Inhalation
1 x 120 actuations, 1 x 180 actuations, 1 x 60 actuations, 3 x 120 actuations, 2 x 120 actuations
(S4) Prescription Only Medicine
COPD TRIMBOW 100/6/10 is indicated for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid (ICS) and a long-acting beta2-agonist (LABA) or a combination of a LABA and a long-acting muscarinic antagonist (LAMA). Asthma TRIMBOW 100/6/10 Maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.
Visual Identification: An aluminium canister with metering valve and grey polypropylene actuator with a red cap and a dose counter or dose indicator; Container Type: Aerosol - Pump Actuated Metered Dose; Container Material: PP/Al; Container Life Time: 20 Months; Container Temperature: Store at 2 to 8 degrees Celsius
Registered
2020-06-24
TRIMBOW AU CMI Ver 6.0 1 TRIMBOW ® _Beclometasone dipropionate, formoterol (eformoterol) fumarate dihydrate and _ _glycopyrronium (as bromide) (100/6/10 micrograms per spray) pressurised inhalation _ _solution_ Consumer Medicine Information WHAT IS IN THIS LEAFLET This leaflet answers some of the more common questions about TRIMBOW. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. Your doctor has weighed the risks of you being given this medicine against the benefits this medicine is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET, YOU MAY NEED TO READ IT AGAIN. WHAT TRIMBOW IS USED FOR TRIMBOW is a medicine to help breathing that contains the three active substances: • beclometasone dipropionate, • formoterol (eformoterol) fumarate dihydrate and • glycopyrronium bromide (glycopyrrolate). Beclometasone dipropionate belongs to a group of medicines called corticosteroids which act to reduce the swelling and irritation in your lungs. Formoterol and glycopyrronium are medicines called long-acting bronchodilators. They act in different ways to relax the muscles in your airways, helping to open the airways wider and allowing you to breathe more easily. Regular treatment with these three active substances helps to relieve and prevent symptoms such as shortness of breath, wheezing and cough in adult patients with chronic obstructive pulmonary disease (COPD). TRIMBOW can reduce flare-ups of COPD symptoms. COPD is a serious long-term disease in which the airways become blocked and air sacs inside the lungs become damaged, leading to difficulty breathing. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY TRIMBOW HAS BEEN PRESCRIBED FOR YOU. This medicine is available only with a doctor’s prescription. BEFORE YOU ARE GIVEN TRIMBOW _WHEN YOU MUST NOT BE _ _GIVEN IT _ TRIMBOW should not be taken if you are allergic to beclometa Đọc toàn bộ tài liệu
TRIMBOW Product Information TRIMBOW PI v7.0 1 AUSTRALIAN PRODUCT INFORMATION - TRIMBOW ® (BECLOMETASONE DIPROPIONATE, FORMOTEROL (EFORMOTEROL) FUMARATE DIHYDRATE AND GLYCOPYRRONIUM BROMIDE (GLYCOPYRROLATE) PRESSURISED INHALATION SOLUTION 1. NAME OF THE MEDICINE Beclometasone dipropionate, formoterol (eformoterol) fumarate dihydrate and glycopyrronium bromide (glycopyrrolate). 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each metered dose (the dose leaving the valve) contains 100 micrograms of beclometasone dipropionate (BDP), 6 micrograms of formoterol fumarate dihydrate (FF) and 10 micrograms of glycopyrronium (equivalent to 12.5 micrograms of glycopyrronium bromide) (GB). Each delivered dose (the dose leaving the mouthpiece) contains 87 micrograms of beclometasone dipropionate, 5 micrograms of formoterol fumarate dihydrate and 9 micrograms of glycopyrronium (equivalent to 11 micrograms of glycopyrronium bromide) (GB). List of excipient(s) with known effect: alcohol. For the full list of excipients see section 6.1 LIST OF EXCIPIENTS. 3. PHARMACEUTICAL FORM Pressurised inhalation solution (pressurised inhalation). Colourless to yellowish liquid solution. The inhalation solution is contained in a pressurised aluminium container sealed with a metering valve. The canister is inserted into a polypropylene plastic actuator which incorporates a mouthpiece and is fitted with a plastic protective cap. The actuator is grey with a red cap. The actuator has a dose counter. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS TRIMBOW is indicated for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid (ICS) and a long-acting beta2-agonist (LABA) or a combination of a LABA and a long-acting muscarinic antagonist (LAMA) 4.2 DOSE AND METHOD OF ADMINISTRATION TRIMBOW is for inhalation use. DOSAGE TRIMBOW is not to be used as initial therapy but may be considered as step-up from LABA/LAMA or ICS/LAB Đọc toàn bộ tài liệu